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Fold designability has been estimated by the number of families contained in that fold. Here, we show that among
orthologous proteins, sequence divergence is higher for folds with greater numbers of families. Folds with greater
numbers of families also tend to have families that appear more often in the proteome and greater promiscuity (the
number of unique ‘‘partner’’ folds that the fold is found with within the same protein). We also find that many disease-
related proteins have folds with relatively few families. In particular, a number of these proteins are associated with
diseases occurring at high frequency. These results suggest that family counts reflect how certain structures are
distributed in nature and is an important characteristic associated with many human diseases.
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Introduction
Different proteins exhibit a wide range of abilities to
functionally withstand the affects of environmental stress or
mutation. One property that has been proposed to contrib-
ute to protein functional robustness is ‘‘designability,’’ the
number of sequences that encode a protein’s structure. Using
simple lattice models in which proteins are modeled as chains
of hydrophobic and hydrophilic residues on lattices, Li et al.
[1] has shown that different proteins could have vastly
different designabilities. Proteins with more designable
structures (i.e., proteins that have more sequences that
encode their structures) were proposed to be structurally
more robust to mutation and thermal stresses [1–3]. In line
with this hypothesis is the ﬁnding that proteins of thermo-
philes exhibited a higher contact trace, a measure that
correlates well with the designability, than a sample of
mesophiles [4].
It has been hypothesized that protein structures of higher
designability tend to be more ﬁt because such structures
would allow a greater amount of sequence changes associated
with a greater diversity of function [5]. To assess designability,
we took advantage of the hierarchical nature of the Structural
Classiﬁcation of Proteins (SCOP) database (http://scop.
mrc-lmb.cam.ac.uk/scop) [6]. In this database, structures with
highly similar sequences are grouped into families, families
sharing a relatively close common ancestor based on high
structural similarity are grouped into superfamilies, and
superfamilies sharing an overall structural similarity are in
turn grouped into folds. It is clear that in such a classiﬁcation
scheme, the number of sequences is always greater than or
equal to the number of families, which are greater than or
equal to the number of superfamilies, which is greater than or
equal to the number of folds (Figure 1). Since a direct
relationship exists between the number of sequences and the
number of families in protein folds [2], a rough estimate of
fold designability had been deﬁned as the number of families
within a fold [7]. This estimate of designability assesses the
ability of a fold to withstand mutations based on the level of
diversity of associated sequences derived under various
functional constraints in its past history. In this work, we
compared family counts within folds and the degree to which
the structures appeared in eukaryotic proteomes. We
subsequently show that families belonging to ancient folds
with greater numbers of families tend to be more sequence
divergent and more widespread throughout the human,
mouse, and yeast proteomes, consistent with the hypothesis
that more designable folds should be more ﬁt.
Because mutation or environmental change can disrupt
and/or create aberrant function in proteins, and given that a
large proportion of mutations seem to affect protein
structure [8–14], hereditary disease–related proteins were
hypothesized to more often contain structures of relatively
low designability as compared to non-disease proteins
(proteins without disease annotation). Preliminary work also
suggests that the majority of disease-causing mutations tend
to be located in structural domains [15]. Protein designability
was subsequently estimated by counting the number of
families in each domain fold and taking the minimum count.
In other words, we assessed the designability of proteins by
the fold estimated to be least designable. Using this measure,
it was shown that disease proteins tended to have folds with
fewer families than non-disease proteins, suggesting that
disease propensity of proteins was related to protein
designability [7].
In this work, we continue to investigate the concept of fold
designability and its connection to hereditary diseases. We
estimate protein designability based on the average family
counts of all folds in a protein and, subsequently, ﬁnd that
many disease proteins contain folds with relatively few
families. In particular, disease proteins were again estimated
to be less designable than non-disease proteins, using this
measure. We also provide evidence using a database of
disease properties that proteins predicted to be less design-
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frequency. Taken together, this work provides further
evidence that designability is a factor important to our
understanding of many of our diseases.
Results
Older Folds Have More Families
A potential problem of estimating designability using
family counts is that relatively young folds may not have
had enough time to establish families, even though the fold
may be encoded by large numbers of sequences. Subsequent
investigation revealed that relatively ancient folds appearing
in both prokaryotes and eukaryotes (see Materials and
Methods) have signiﬁcantly more families than all the SCOP
folds in human proteins (Figure S1). Eukaryotic folds found
only in human, mouse, and yeast currently contain only
approximately 2.5 families, on average, compared to an
average of 13.8 families per fold for all human proteins. Thus,
time seems to be a signiﬁcant factor in determining how
many families are found in a fold. To minimize the inﬂuence
of inadequate time for the procreation of fold families on our
estimate of designability, we concentrated subsequent inves-
tigations on ancient folds. Results pertaining to all human
folds are found in the supplementary materials.
Folds with More Families Tend to Be More Sequence
Divergent
We ﬁrst compared the sequence divergence among ancient
SCOP folds in human proteins against the number of families
they contain using protein orthologs in mouse and yeast.
Because orthologs were compared, the domains being
compared belong to the same family (see Materials and
Methods). In general, it was found that families that belong to
ancient SCOP folds with greater numbers of families tended
to be more sequence divergent (Figure 2). This trend was also
observed when we restricted our analysis to SCOP folds
created relatively close to the origin of the human–mouse
common ancestor (Figure S2). A similar trend was observed
when all folds were analyzed, although the signiﬁcance of the
Figure 2. Sequence Divergence and Family Counts of Ancient Folds
Ancient SCOP folds found in human proteins were compared to those in
mouse and yeast orthologs (see Materials and Methods), and the average
divergence was recorded for each fold. The SCOP folds were divided into
a number of bins according to the number of families that they contain
(x-axis). The mean of the sequence identities in each bin is shown (y-axis)
for mouse and yeast. For both organisms, as the number of families in a
SCOP fold increases, the sequences that encode the fold become more
divergent. Against mouse orthologs, folds with one family were
significantly more conserved than those with more than one family
(MW-test, Kolmogorov-Smirnov test [KS-test]: p , 0.01). Against yeast
orthologs, a significant difference in divergence was observed between
folds of one and more than ten families (MW-test, KS-test: p , 0.05).
DOI: 10.1371/journal.pcbi.0020040.g002
Figure 1. SCOP Hierarchy
Four levels of SCOP are shown: fold, superfamily, family, and sequence
(dark blue rectangles). The number of sequences is equal to or greater
than the number of families, which is equal to or greater than the
number superfamilies, which in turn is equal to or greater than the
number of folds.
DOI: 10.1371/journal.pcbi.0020040.g001
PLoS Computational Biology | www.ploscompbiol.org May 2006 | Volume 2 | Issue 5 | e40 0393
Synopsis
Most proteins are composed of structural domains that can be
classified into ‘‘folds.’’ Domains with the same fold type share
overall structural similarity. The number of amino acid sequences
that encode a fold is termed the ‘‘designability’’ of the fold. Folds
that have higher designability are thought to be more robust to
stresses and mutations. Such features may also allow the fold to
appear in a greater variety of contexts. Here, the authors show that
proteins with folds estimated to be of higher designability are more
widespread amongst proteins in human, mouse, and yeast,
consistent with this hypothesis. The authors also find that many
hereditary disease-associated proteins have folds estimated to be of
low designability. A number of these diseases occur at a relatively
high frequency. These results suggest that the estimate of
designability employed reflects how certain structures are distrib-
uted in nature and is an important characteristic associated with
many human diseases.
Fold Designability, Distribution, and Diseasetrend could not be established (Figure S3). These results
suggest that family counts in folds are associated with the
divergence of these folds.
Ancient Folds with More Families Are More Fit
A possible consequence of higher designability is that of
greater ﬁtness. We reason that more designable folds would
be more robust to sequence changes associated with a greater
diversity of functionality, and thus would be found more
often in a proteome in a greater variety of functional
contexts. To test if our measure of designability correlates
with fold ﬁtness in the eukaryotic proteome, ancient folds
from human, mouse, and yeast were binned according to the
number of families they contain. For folds in each bin, the
number of proteins each fold appeared in was counted and
averaged. It was found that ancient folds with greater
numbers of families appeared in greater numbers of different
proteins (Figure S4). This result was not unexpected because,
in general, larger numbers of families tend to be encoded by
larger numbers of sequences. Do individual families that
belong to folds with more families appear more often in the
proteome? For all families that belong to folds in each bin,
the number of proteins each family appeared in was also
counted and averaged. It was found that families that
belonged to ancient folds with greater number of families,
appeared in greater numbers of different proteins (Figure 3).
A related measure of fold ﬁtness is that of fold promiscuity.
We deﬁne ‘‘fold promiscuity’’ as the number of unique
‘‘partner’’ folds in the entire proteome, that a particular fold
had appeared with in the context of the same protein. We
found that ancient folds with more families also tended to be
more promiscuous (Figure 4). Graphically, if folds were
represented as nodes, and edges connected folds if they were
found in the same protein, folds with more families would be
more hub-like. These results are consistent with the hypoth-
esis that more designable folds are more ﬁt, because they
appear in larger numbers of proteins in a greater variety of
sequence contexts. The same trends were observed in M.
musculus and S. cerevisiae proteomes.
A third measure of fold ﬁtness is the number of times that a
fold is reused in a given protein. A fold is considered here to
be duplicated within the same protein if more than one
instance of it exists in that protein. Duplication of folds
within a protein allows either for ampliﬁcation of existing
functions associated with such folds or creation of new
functions. Folds with different functionality are likely
encoded by different sequences. Sequence dissimilarity may
also be selected for in folds cooperating to amplify a single
function because individual folds must function in different
spatial contexts. Indeed, of the 3,468 human proteins that
have duplicate folds, less than 7% (230/3,468) have such folds
detected with the same BLASTP E-value (see Materials and
Methods). Sufﬁcient dissimilarity may also help sequences
avoid aggregation [16]. More designable folds would allow for
a greater variety of sequence change necessary for viable
duplications. Examination of our human proteins revealed
that ancient folds with more families are reused more often
in the same protein (Figure 5). Although statistical signiﬁ-
cance could not be established, SCOP families (structures that
Figure 3. Family Occurrence and Family Counts of Ancient Folds
Ancient SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). For each bin, the mean
family occurrence (the mean number of proteins in which the SCOP
families in these folds appear) for human, mouse, and yeast proteins is
shown. As the number of families in a SCOP fold increases, the
occurrence of families belonging to these folds in the proteome tends to
increase. Significant (MW-test, KS-test: p , 0.05) occurrence differences
were found between folds of one and more than ten families in human
and mouse. No significant differences were detected in yeast. The
differences in mean family occurrence between mammals and yeast tend
to be larger for folds with larger numbers of families. The differences in
mean family occurrence between mammals and yeast tend to be larger
for folds with larger numbers of families. These interspecies differences
between folds of one family and those of more than one family are
significant (MW-test: p , 0.1; KS-test: p , 0.001).
DOI: 10.1371/journal.pcbi.0020040.g003
Figure 4. Fold Promiscuity and Family Counts of Ancient Folds
Ancient SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). SCOP folds are connected
to other ‘‘partner’’ folds in the same protein. The mean promiscuities
(the number of unique partner folds a SCOP fold has) of folds in human,
mouse and yeast are plotted. As the number of families in a SCOP fold
increases, its promiscuity tends to increase. The differences in fold
promiscuity between human, mouse, and yeast are larger for folds with
larger numbers of families. All promiscuity differences described here
between folds with one family and folds with more than one family are
significant (MW-test, KS-test: p , 0.02).
DOI: 10.1371/journal.pcbi.0020040.g004
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Fold Designability, Distribution, and Diseaseare likely to be closely related) that belong to more folds with
more families were observed to be duplicated more often in
the same protein (Figure S5). The same trends were observed
in M. musculus and S. cerevisiae proteomes.
Observations across multiple genomes allow one to
compare the occurrence of associated phenomena within
the timeframe delineated by the divergence of these genomes.
Three different proteomes belonging to modern human,
mouse, and yeast have emerged from the time of the common
ancestor of these organisms. Within this ﬁxed timeframe, the
proteomes leading up to modern mammals have expanded
considerably compared to those leading up to the yeast
proteome. In particular, we found that the magnitude of
differences between yeast and mammals in terms of fold
occurrence, promiscuity, and duplication is much higher for
ancient folds with larger numbers of families (Figure S4;
Figures 4 and 5). These differences were also noticeable
between human and mouse (Figures 3–5; Figure S4). The top
ten folds that have expanded the most are listed in Protocol
S1. It seems that given the opportunity or need, structures of
higher designability can proliferate more throughout pro-
teomes, through events such as horizontal transfer, duplica-
tion, and recombination, within a ﬁxed evolutionary
timeframe. Taken together, these results provide further
evidence that ancient folds estimated to be more robust to
sequence or environmental change can be found more often
in different contexts within eukaryotic proteomes.
Although our investigation has focused thus far on the
divergence and proliferation of ancient folds, we also detect
similar trends when we examined all folds and families within
these folds (Figures S3–S12). Statistical signiﬁcance of the
trends in some cases could not be established. Interestingly,
similar trends were also observed amongst gamma-proteo-
bacteria (Figures S13–S17), suggesting that the relationships
between family counts, fold divergence, and proliferation are
not speciﬁc only to eukaryotes.
Increased Age Does Not Imply Increased Fold Divergence
and Proliferation
Thus far, older folds were found to have more families, and
folds with more families were found to be more divergent and
widespread. Thus, a possible explanation as to why folds with
more families are more divergent and widespread within
genomes is that these folds tend to be older. To test this
hypothesis we compared ancient folds and young folds found
only in human and mouse (see Materials and Methods) in
terms of these attributes. In contrast to what we expected, we
found that ancient folds tend to be more conserved than
young folds (Figure S18). No statistically signiﬁcant differ-
ences in terms of occurrence (Figure S19) and duplication
within proteins (Figure S20) could be found between young
and old folds. Ancient folds were found to be marginally
more promiscuous than young folds (Figure S21). At the
family level, ancient families were found to be signiﬁcantly
less abundant, promiscuous, and duplicated than young
families found only in mouse and human (Figures S18–S21).
Families belonging to ancient folds were also found to be less
abundant, promiscuous, and duplicated than those belonging
to young folds (unpublished data). These results are opposite
to what we have hypothesized, suggesting that increased age
does not necessarily elevate divergence and proliferation
levels of protein structures.
Little Correlation between Family Counts and Fold Length
The number of sequences that encode a fold has been
hypothesized to be related to the length of the fold [5]. In
contrast to this hypothesis, we found little correlation
between the fold length and family counts (Figure S22).
Designability and Disease
Using the SCOP hierarchy, the designability of proteins was
estimated in two ways: (1) as the number of families in the
fold predicted to be least designable [7] and (2) as the mean
family count across all detected folds in proteins in which
SCOP had high coverage (see Materials and Methods).
Although the second method reduces the number of proteins
available for analysis, it ensures that most residues in the
protein chain contribute to the designability measure. Using
both methods, disease proteins were predicted to be less
designable on average than non-disease proteins (Table 1),
with a disproportionate number of disease proteins having
folds containing only one family (Protocol S2).
Although biased toward the populations assessed and
limited in quantity, data pertaining to disease frequency
[17] were also examined. Proteins associated with common
diseases were predicted to be less designable than proteins
associated with rare diseases (Table 1; Protocols S3–S4).
Although a relatively high p-value was obtained with the
Mann-Whitney (MW-test) when comparing designability
values generated with the ﬁrst method, a much lower p-value
Figure 5. Fold Duplication and Family Counts of Ancient Folds
Ancient SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). The maximum number of
times each fold is reused in the same protein was counted. The mean
count for each bin is shown for human, mouse, and yeast proteins. As
the number of families in a SCOP fold increases, the maximum number of
times the fold is duplicated in proteins also tends to increase. The
differences in magnitude of duplication between folds with one family
and folds with more than one family are significant (MW-test, KS-test: p
, 0.01). The differences in fold duplication between human, mouse, and
yeast are larger for folds with larger numbers of families. The differences
between folds with one family and folds with more than one family with
respect to mammals and yeast are significant (MW-test: p , 0.05; KS-test:
p , 0.001). The significance of the differences between human and
mouse could not be established.
DOI: 10.1371/journal.pcbi.0020040.g005
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analyzed had high SCOP coverage.
Discussion
In this and a previous work [7], we estimated SCOP fold
designability by the number of families found within that
fold. In other words, we estimate the number of sequences
that encode a fold by its level of divergence achieved in its
past history. One confounding factor for this measure is that
the number of families found within a fold could depend on
the time the fold existed [18]. We found that ancient folds had
signiﬁcantly more families than relatively young folds found
only in mouse and human. Thus, certain relatively young
folds may exist, which may be highly designable, may not have
had enough time for different families to evolve, and thus
would be predicted to be less designable by our measure.
Furthermore, since SCOP is largely based on manual
annotation of known protein structures, a bias exists in the
classiﬁcation in terms of what sequences have been mapped
to structures [19] and how these sequences are classiﬁed into
folds. It is not known what effect this bias has on the use of
family counts to estimate designability. The question arises as
to whether family counts reﬂect what we expect to be
properties of more designable structures and whether these
properties are observable in nature.
To ensure adequate time was available for family procre-
ation among folds to be examined, we concentrated our
analysis on relatively ancient folds found both in eukaryotes
and prokaryotes. Protein families belonging to ancient folds
containing more families were found in larger numbers of
proteins. Ancient folds with greater numbers of families were
also found in partnership with a more diverse set of other
folds, and were duplicated more often within the same
protein. In particular, the expansion of families belonging to
ancient folds with more families was found to be greater since
the time of the yeast–mouse–human common ancestor. These
results are also consistent with the hypothesis that folds with
more families are more designable. More designable folds
would allow for a larger number of sequence changes in a
fold, allowing for greater diversity of function. This line of
thought concerning protein folds is analogous to recent
ﬁndings that designability correlates with contact density,
which correlates with the mean functional ﬂexibility score of
gene families [18]. A fold that can exhibit greater function-
ality would be at an evolutionary advantage because it can
appear in a greater variety of contexts. A strong correlation
between fold promiscuity and occurrence suggests that fold
recombination occurs nearly randomly [20]. Other factors
such as evolutionary history or the need for functions
associated with a fold or fold combinations seem to have
also inﬂuenced the frequency in which certain folds appear in
proteomes [6,18,20,21] (see Protocol S5). Our ﬁnding that
folds with more families are more abundant and promiscuous
in proteomes does reﬂect the expected increased ﬁtness of
more designable folds. It lends to speculation that desig-
nability is an important factor affecting how folds are
distributed within proteomes and their potential for evolu-
tion of new functions via sequence mutations. Although
exceptions exist, the assumption that the number of families
that belong to a given fold is a good estimate of the fold’s
evolutionary success [5] appears to be largely valid.
Fold designability deﬁnes a limit to the divergence
associated with folds. Interestingly, we ﬁnd that sequences
belonging to folds with greater numbers of families were
more divergent in orthologous proteins. Clearly, selection
would affect the divergence of folds. However, if family
counts capture the designability of a fold, these results also
suggest that designability may have contributed signiﬁcantly
in limiting the divergence of folds. It would be highly
interesting to tease apart structural and selective inﬂuences
on divergence in the future.
Because older folds have more families, and folds with
more families are more widespread and divergent, one might
presume that folds are more widespread and divergent simply
because they are older. We found that ancient folds were not
necessarily more widespread than young folds in terms of
occurrence and duplication, but were found to be more
promiscuous, perhaps due to greater opportunity for
recombination. Ancient folds were also found not to be
more divergent than young folds. Abeln and Deane [22] have
also previously noted that old folds do not necessarily have
many copies in genomes. The relationship between time and
fold divergence is similar to previous ﬁndings that older
mammalian proteins tend to be more conserved [23]. Thus,
our analysis revealed that the greater divergence, occurrence,
and duplication observed for folds with more families is not
simply an artifact of their tendency to be older.
Our inability to ﬁnd a relationship between length of folds
and the number of families contained within folds may be the
result of the limited number of structures known. It also
raises speculation that increasing the length of folds does not
necessarily increase their designability, perhaps due an
increase in the potential for aberrant misfolding and
aggregation [7].
It is worth noting that the associations between family
counts, divergence, and fold proliferation in genomes were
statistically weakened when we considered all folds instead of
Table 1. Designability and Disease Frequency
Protein Group (I) Mean
Designability of
the Least
Designable Folds
(II) Mean
Designability
across Folds
Score Number of
Proteins
Score Number of
Proteins
Non-disease 13.3 9,274 12.1 2,543
All disease proteins 11.6 801 10.4 218
Common diseases
(freq. , 1:10,000)
10.2 33 7.2 15
Rare diseases
(freq.   1:10,000)
12.7 265 13 88
ENSEMBL proteins with detectable SCOP folds were divided into different disease
categories [17]. Proteins without any disease annotation were classified as non-disease
proteins (first row). Mean designability scores, measured as (I) the family count of the least
designable fold and (II) the mean family count across all folds in proteins highly covered
by SCOP (see Materials and Methods), are shown for each category along with the
number of proteins in each category. Disease proteins were found to be less designable
than non-disease proteins (I: MW-test: p , 0.01; KS-test: D . 20%, p , 0.01; II: MW-test: p
, 0.07; KS-test: D . 16%, p , 0.01). Proteins associated with common diseases tend to be
less designable than rare disease proteins (I: MW-test: p , 0.16; KS-test: D . 30%, p ,
0.01; II: MW-test: p , 0.03; KS-test: D . 69%, p , 0.01).
DOI: 10.1371/journal.pcbi.0020040.t001
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idea that relatively young folds may not have had enough
time to procreate families, thus obscuring trends between
these attributes.
Early structural characterization of the human proteome
indicated signiﬁcant differences in SCOP superfamily com-
position between disease and non-disease proteins [24]. In
this and a previous work [7], it was found that disease proteins
tend to have folds with fewer families than non-disease
proteins (see Protocol S2). One cannot rule out that such a
trend is a product of bias in our disease data. Nevertheless,
about one third of folds in disease proteins with only one
family are relatively ancient folds (see Materials and
Methods), and it is a mystery why many families have not
evolved. Our results do suggest that many disease proteins
have structures that have been relatively sequence con-
strained throughout their evolution. The form of this
constraint may have involved the lowering of the ﬁtness of
ancestral organisms upon mutation of such structures. If
similar constraints are maintained in humans for a sufﬁcient
number of proteins, then this may help explain why disease
proteins tend to have folds with fewer families. Two-thirds of
folds in disease proteins, however, are relatively young (most
of which are found only in mouse and human) and thus would
be predicted to be relatively less designable by contact-
residue–based measure of designability [18] compared with
ancient folds.
Interestingly, we found that within a database of disease
properties, more frequently occurring diseases were associ-
ated with proteins containing folds with fewer families.
Theoretically, proteins with less-designable folds would be
less robust to mutation. Such a characteristic suggests two
reasons why proteins predicted to be less designable have
been associated with more common diseases. First, proteins
with lower structural robustness would be more likely to
receive disease-associated mutations. Our results lend to
speculation that an increased chance for deleterious muta-
t i o n si np r o t e i n sp r e d i c t e dt ob el e s sd e s i g n a b l eh a v e
contributed to their association with more frequently
occurring diseases. Second, one would also expect the
diversity in terms of structure and stability of less-robust
proteins to be greater in a population. Such diversity in
structure or stability is likely correlated with functional
diversity because proteins of different structures usually
perform different functions, and proteins of different
stabilities would likely have different cellular lifetimes. Such
diversity would facilitate the survival of a population in
rapidly changing environments because certain members are
more likely to contain a mutation adapted to the new
environment. These mutations, however, may cause disease
directly or increase susceptibility to diseases. For example,
over 100 mutations in G6PD that increase the risk of
hemolytic anemia may provide resistance to malaria out-
breaks [25,26]. In such a scenario, less-designable proteins
would become associated with common diseases because
members with mutations in these proteins would be more
likely to survive. Subsequent population expansion would
increase the number of individuals with disease-prone
proteins, and bottlenecks would increase the frequency with
which these diseases occur in populations [27].
Analogous to a decrease in designability, an increase in
length has been proposed to increase the likelihood of a
protein receiving disease-causing mutations [28]. Notably,
diseases that occur more frequently have also been associated
with longer proteins [29]. Longer proteins may also possess a
greater diversity of mutations in a population, thus confer-
ring functional diversity, especially if the mutations are
distributed among different domains that carry out different
functions. Like with less-designable proteins, it is possible
that certain large proteins have been associated with common
diseases because they had a greater chance of possessing a
disease-causing mutation that happened to be beneﬁcial in
the past.
What has not been considered so far is the propensity for
precursor molecules encoding proteins to undergo disease
causing alterations. For example, certain genomic contexts or
hotspots have been identiﬁed that predispose DNA sequences
for mutation [30,31]. If these sequences happen to encode
proteins of low designability, then such proteins would be
associated with diseases of greater occurrence. For example,
the gene associated with Gaucher’s disease has pseudogenes
that predispose the gene for disease-causing gene conversion
events [32]. The associated protein contains the gycosyl
hydrolase fold, a fold with only three known families. Thus, a
protein with a fold seemingly constrained against sequence
divergence has been associated with the increased potential
for mutation associated with pseudogenes. Another example
involves the genes OPN1LW and OPNL1MW encoding red and
green photopigment proteins containing the Family AG
protein–coupled receptor-like fold (f.13) that has only two
known families. Their high sequence similarity and tandem
arrangement have been thought to predispose these genes for
disease-causing recombination events [33]. Such associations
between folds of low designability and genomic contexts that
increase mutation propensity suggest that maintenance of
polymorphism in corresponding genes has been selected for,
perhaps to ensure differences amongst individuals that
confer advantages to the population. This reasoning may
help explain why certain duplicate genes are retained [34,35].
In the case of vision-related genes, variation in perception
may help groups exploit a wider range of niches [36,37]. What
selective advantage Gaucher’s disease gene polymorphism
would confer remains an open question. Interestingly, recent
comparisons between disease and non-disease genes revealed
a signiﬁcant excess of highly polymorphic genes constrained
for divergence associated with disease [38]. The association
between folds with fewer families with increased mutability in
encoding regions may explain in part this observation.
To what extent intrinsic susceptibility to mutation and
selection on populations has contributed to the association of
diseases with proteins with few families is not known. The
former mechanism suggests that a larger number of disease
alleles exists for more common diseases. The latter mecha-
nism suggests that a small number of common disease alleles
in the population account for the high frequency of
occurrence in human diseases [27]. Comparisons of disease
allele frequencies between common and rare diseases when
sufﬁcient data become available may shed more light on this
phenomenon. Whatever the dominant mechanism may be,
the results of comparing length and fold family counts against
disease frequency do suggest a general principle that proper-
ties that increase a protein’s propensity for disease associa-
tion would also increase the frequency that the associated
diseases would appear in certain populations.
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with SCOP folds detected from our Ensembl database have
been mapped to disease frequency categories. Disease
frequency is inﬂuenced by many factors, including environ-
mental effects and underlying genotypes. Thus, the disease
frequency data we use may not reﬂect certain populations.
Although we have provided evidence for an association
between disease and SCOP family counts, the nature of this
association is not known for many proteins. The extent to
which our explanations hold as to why diseases are associated
with proteins predicted to be less designable remains to be
assessed. Establishment of principles based on our work
would require further investigation on larger datasets
accounting for multiple factors that inﬂuence disease
propensity.
Throughout this work, we have extensively used family
counts as an estimate of fold designability. How many
sequences can encode a protein fold depends, not only on
the intrinsic constraints imposed by the geometry of the fold,
but also on the external environment. For example, high
temperatures could restrict the sequence space occupied by
folds [4], whereas the presence of chaperones [39–41] and
proteases [42] could do the opposite. These molecules allow
sequences more likely to misfold to exist by preventing or
reversing misfolding events (in the case of chaperones) or
degrading the fraction of deleterious misfolded sequences (in
the case of proteases). Family counts may capture, not only
the intrinsic designability of a fold, but also the degree of
success of the fold within the multitude of environments and
ﬁtness constraints experienced throughout the history of the
fold. The use of family counts to estimate fold designability
assumes that the past success of a fold implies its future
designability.
A major disadvantage of using family counts is that it is an
imprecise measure. It is likely that different proteins with the
same folds, and hence the same family count scores, can have
vastly different designabilities. Moreover, if the fold is
relatively young, the number of families contained in that
fold may be too small to reﬂect its designability. Although
residue contacts [18], oligomerization states [43], and molec-
ular interactions are not direct measures of sequence
divergence success, these properties are more speciﬁc to
individual proteins and may help distinguish designability
differences between proteins with similar folds. Data on gene
mutation frequency and expression [44–46] may also prove
useful in predicting designability. To this day, no compre-
hensive experiments have been conducted to investigate the
relationship between different folds and their ability to
withstand environmental stress or mutation. Screening
random sequences for ones that fold is one approach [5] to
investigate designability. Testing the foldability and function-
ality of different proteins after mutagenesis in different
environments (in vivo or in vitro) is another approach [47–
50]. Such experiments are likely to provide new information
important to reﬁning measures of designability and its use to
estimate fold ﬁtness. It would be highly interesting to repeat
experiments carried out in this work using a greater variety of
designability measures.
In summary, we have provided evidence that family counts
can capture characteristics of fold designability. By estimat-
ing fold designability, we suggest explanations regarding how
folds are distributed in proteomes and their potential for
evolution. We have also provided evidence that our measure
of protein designability is associated with properties of
diseases. The designability concept remains immature [5],
but our work suggests that it may already have practical
applications. With further development of this concept,
further insights into the evolution of proteins and desig-
nability’s relation to diseases are anticipated.
Materials and Methods
Proteomes and disease annotation. A total of 34,111 proteins
predicted to be encoded in the human genome were obtained from
the Ensembl human v23.34e.1 database [51]. OMIM-based [52] disease
annotations for human genes were obtained using the EnsMart tool
[53] and mapped to 2,113 proteins in the Ensembl protein dataset.
OMIM is a database focused mostly on heritable genetic diseases of
high penetrance. For inter-species comparisons, the PEDANT [54]
mouse and yeast [55] genomes encoding 42,049 and 6,723 proteins,
respectively, were used. Common and rare disease annotation was
taken from Jimenez-Sanchez et al. [17]. The associated proteins,
covering a wide variety of phenotypes, are listed in Protocols S3 and
S4.
Protein fold assignments. Protein SCOP [6] (December 2004)
assignments were obtained from the PEDANT system. SCOP folds
were assigned to proteins if the corresponding sequences were within
a BLASTP [56] E-value of 10
 6. Our conclusions did not change when
an E-value threshold of 10
 2 was chosen instead (unpublished data).
For the analysis of disease proteins, only the largest protein encoded
by each gene was included as done by Lo ´pez-Bigas and Ouzounis [28].
Ancient folds and families. Folds identiﬁed in human and more
than six other genomes (Bacteroides fragilis NCTC9434, Mus musculus,
Deinococcus geothermalis, Escherichia coli K12, Vibrio ﬁscheri ES114,
Psychrobacter arcticum 273 4, Chlorobium vibrioforme, Sulfolobus acid-
ocaldarius DSM, Saccharomyces cerevisiae, Mycoplasma hyopneumoniae 232,
Streptococcus zooepidemicus, and Anabaena variabilis) were considered to
be relatively ancient. Similarly, we deﬁned relatively ancient families
as those families appearing in human and six other genomes. Our
conclusions did not change if we considered domains appearing in
human and two other genomes (one of which is a prokaryote) as
ancient.
Sequence divergence and fold designability. To test whether the
number of families found within folds correlated with their
divergence, the number of families associated with each SCOP fold
was compared with the sequence divergence of that fold. Individual
SCOP domains from human proteins were aligned with the
corresponding domains found within corresponding mouse and
yeast protein orthologs, and the sequence identity was recorded.
Protein orthologs between human, yeast, and mouse were identiﬁed
as bidirectional best BLASTP hits with exactly the same SCOP
domains. Note that the strict ortholog deﬁnition in use ensures that
the SCOP domains being compared belong to the same SCOP family.
Sequence identity between the SCOP families were computed using
ClustalW [57] with default parameters. Subsequently, the divergence
for each SCOP fold was measured by computing the average
divergence of individual SCOP families within that SCOP fold and
then taking the average (see Figure 6 for a detailed example). We term
this result the ‘‘average divergence’’ of a SCOP fold. By comparing
domains between ortholog pairs, we hoped to minimize the potential
for large sequence divergence contributions due to functional
differences between proteins of vastly different functions.
For human and mouse comparisons, we also deﬁned orthologs as
those genes encoding proteins with the same SCOP families and that
are bidirectional best hits with at least one nearby gene being a
bidirectional best hit to a gene nearby its ortholog. We deﬁne nearby
genes of gene A as those genes within ﬁve genes of A. Using this
orthology deﬁnition, we obtained similar results (unpublished data).
Protein designability measures. Protein designability was meas-
ured as done in Wong et al. [7], by counting the number of families in
each SCOP fold contained in a given protein and taking the
minimum. For example, if protein A contains three domains with
folds F1, F2, and F3 and these folds in turn contain eight, three, and
seven families, respectively, protein A’s minimum family count would
be three. By recording the minimum family count of the folds in
proteins, we assessed their designability by assessing the designability
of their least designable fold.
We also assessed protein designability using a measure that ensures
most residues that take part in structural domains in the protein
PLoS Computational Biology | www.ploscompbiol.org May 2006 | Volume 2 | Issue 5 | e40 0398
Fold Designability, Distribution, and Diseasechain contribute to the designability score. This was done by
measuring designability by the mean number of families across all
folds in each protein. In our example, the score for this measure
would be (8 þ 3 þ 7)/3 ¼ 6. The SCOP folds detected in this work,
however, do not necessarily cover the entire protein, simply because
either no such structure has been solved yet or the non-covered
regions may be intrinsically disordered. Thus, we apply this measure
to only those proteins that do not have regions longer than 70 amino
acids that have not been covered by our SCOP detection methods.
Fold binning. Because of substantial scattering within plots,
analysis was conducted using four bins to emphasize trends: Folds
containing only one family, more than one family, more than ﬁve
families and more than ten families. The last three bins overlap with
each other.
Supporting Information
All supporting information is available to download as a combined
ﬁle called Combined Supporting Information.
Figure S1. Number of Families and Fold Age
The mean number of families found in all, ancient (see Materials and
Methods), and human/mouse/yeast-only folds are shown. The mean
number of families in all three groups are signiﬁcantly different from
each other (MW-test, KS-test: p , 0.01) with ancient folds having the
most families. Standard deviations of family counts are 19, 21, and 3
amongst all, ancient, and human/mouse/yeast folds, respectively.
Found at DOI: 10.1371/journal.pcbi.0020040.sg001 (22 KB PDF).
Figure S2. Divergence of SCOP Folds and Families within a Time
Interval
SCOP domains found in Ensembl human proteins likely to be
mammalian in origin were compared to orthologous domains in
mouse, and the average divergence was recorded (see Materials and
Methods). Only domains found in human and mouse and not in yeast
or a number prokaryotes (see Materials and Methods) were
considered likely to be mammalian in origin. The SCOP folds were
divided into a number of bins according to the number of families
that they contain (x-axis). The mean of the sequence identities
associated with domains in each bin is shown (y-axis). At the fold level
(black bars), folds with more than one family were more divergent
than folds containing only one family. This trend is considered
marginally signiﬁcant (MW-test: p , 0.05, KS-test: p , 0.15). At the
family level, families belonging to folds with more than one family
were more divergent than those belonging to folds containing only
one family (white bar). This trend was found to be signiﬁcant (MW-
test, KS-test: p , 0.01). Similar trends were observed when we
considered only domains found in human, mouse, and yeast.
However, signiﬁcance could not be established for unknown reasons.
Found at DOI: 10.1371/journal.pcbi.0020040.sg002 (25 KB PDF).
Figure S3. Mean Sequence Divergence and Family Counts of All
Folds
SCOP folds found in Ensembl human proteins were compared to
those in mouse and yeast orthologs, and the average divergence was
recorded for each fold (see Materials and Methods). The SCOP folds
were divided into a number of bins according to the number of
families that they contain (x-axis). The mean of the sequence
identities in each bin is shown (y-axis) for mouse and yeast. For
mouse, as the number of families in a SCOP fold increases, the
sequences that encode the fold become more divergent. For yeast, a
relatively sharp drop in sequence identity scores occurs beyond a
family count of ten. Statistical signiﬁcance of the trends could not be
established.
Found at DOI: 10.1371/journal.pcbi.0020040.sg003 (27 KB PDF).
Figure S4. Fold Occurrence and Family Counts of Ancient Folds
Ancient SCOP folds were divided into a number of bins according to
the number of families that they contain (x-axis). For each bin, the
mean fold occurrence (the number of proteins the SCOP folds
appear in) for human, mouse, and yeast proteins is shown. As the
number of families in a SCOP fold increases, its occurrence in the
proteome tends to increase. The differences in fold occurrence
between human, mouse, and yeast are larger for folds with larger
numbers of families. The differences between folds with one family
and folds with more than one family within and between the three
eukaryotes are signiﬁcant (MW-test, KS-test: p , 0.001).
Found at DOI: 10.1371/journal.pcbi.0020040.sg004 (24 KB PDF).
Figure S5. Family Duplication and Family Counts on Ancient Folds
Ancient SCOP folds were divided into a number of bins according to
the number of families that they contain (x-axis). The maximum
number of times SCOP families in each fold bin were reused in the
same protein was counted. For each bin, the mean count for human,
mouse, and yeast proteins is shown. As the number of families in a
SCOP fold increases, the maximum number of times families
belonging to that fold is duplicated in proteins also tends to increase.
However, the signiﬁcance of this trend could not be established. The
Figure 6. Average Divergence Calculations
The average divergence of the fold is calculate as follows: Let one genome encode the proteins A, B, and C and another genome encode the proteins
A1, B1 and C1. Let domain F be the hypothetical SCOP fold x.1 in proteins A, A1, B, B1, C, and C1. (A, A1), (B, B1) and (C, C1) are orthologous pairs. Fold
x.1 contains only two families, denoted x.1.1.1 and x.1.1.2. The domains (that belong to the same family) are aligned. The average divergence for
families x.1.1.1 and x.1.1.2 is (40% þ 80%)/2 ¼ 60% and (50% þ 50%)/2 ¼ 50%, respectively. The average divergence for fold F would be taken as the
mean of the average divergence of all its families, namely (60% þ 50%)/2 ¼ 55%.
DOI: 10.1371/journal.pcbi.0020040.g006
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yeast are larger for folds with larger numbers of families, but
signiﬁcance of this trend could not be established.
Found at DOI: 10.1371/journal.pcbi.0020040.sg005 (24 KB PDF).
Figure S6. Family Occurrence and Family Counts of All Folds
SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). For each bin, the mean
family occurrence (the mean number of proteins in which the SCOP
families in these folds appear) for human, mouse, and yeast proteins
is shown. As the number of families in a SCOP fold increases, the
occurrence of families belonging to these folds in the proteome tends
to increase, although statistical the signiﬁcance of this trend could
not be established. The differences in mean family occurrence
between mammals and yeast tend to be larger for folds with larger
numbers of families. These differences between folds of one family
and those of more than one family were signiﬁcant (MW-test: p , 0.1;
KS-test: p , 0.001).
Found at DOI: 10.1371/journal.pcbi.0020040.sg006 (25 KB PDF).
Figure S7. Fold Promiscuity and Family Counts of All Folds
SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). SCOP folds are
connected to other ‘‘partner’’ folds in the same protein. The mean
promiscuities (the number of unique partner folds a SCOP fold has)
of folds in human, mouse, and yeast are plotted. As the number of
families in a SCOP fold increases, its promiscuity tends to increase.
The differences in fold promiscuity between human, mouse, and yeast
are larger for folds with larger numbers of families. All promiscuity
differences shown here between folds with one family and folds with
more than one family are signiﬁcant (MW-test, KS-test: p , 0.05).
Found at DOI: 10.1371/journal.pcbi.0020040.sg007 (24 KB PDF).
Figure S8. Family Promiscuity and Family Counts of Ancient Folds
SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). SCOP families are
connected to other ‘‘partner’’ families in the same protein. The mean
promiscuities (the number of unique partner families a SCOP family
has) of families in human, mouse, and yeast are plotted. As the
number of families in a SCOP fold increases, the promiscuity of its
families tends to increase. However, of the three species, only human
family promiscuity differences between folds with one family and
folds with more than one family were found to be signiﬁcant (MW-
test, KS-test: p , 0.07). The differences in family promiscuity between
human, mouse, and yeast are larger for folds with larger numbers of
families. The family promiscuity differences between folds of one and
more than one family between mammals and yeast were found to be
signiﬁcant (MW-test, KS-test: p , 0.05).
Found at DOI: 10.1371/journal.pcbi.0020040.sg008 (24 KB PDF).
Figure S9. Family Promiscuity and Family Counts of All Folds
SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). SCOP families are
connected to other ‘‘partner’’ families in the same protein. The mean
promiscuities (the number of unique partner families a SCOP family
has) of families in human, mouse, and yeast are plotted. As the
number of families in a SCOP fold increases, the promiscuity of its
families tends to increase. The differences in family promiscuity
between human, mouse, and yeast are larger for folds with larger
numbers of families. Statistical signiﬁcance of the trends could not be
established.
Found at DOI: 10.1371/journal.pcbi.0020040.sg009 (23 KB PDF).
Figure S10. Fold Duplication and Family Counts of All Folds
SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). The maximum number
of times each fold is reused in the same protein was counted. The
mean count for each bin is shown for human, mouse, and yeast
proteins. As the number of families in a SCOP fold increases, the
maximum number of times the fold is duplicated in proteins also
tends to increase. The differences in magnitude of duplication
between folds with one family and folds with more than one family
are signiﬁcant (MW-test, KS-test: p , 0.05). The differences in fold
duplication between human, mouse, and yeast are larger for folds
with larger numbers of families. The increase in fold duplication in
mammals compared with yeast between folds with one family and
folds with more than one family are signiﬁcant (MW-test: p , 0.05;
KS-test: p , 0.001). The differences between human and mouse were
much less pronounced achieving signiﬁcance only between folds of
one family and those of more than ten families (MW-test: p , 0.1; KS-
test: p , 0.001).
Found at DOI: 10.1371/journal.pcbi.0020040.sg010 (25 KB PDF).
Figure S11. Family Duplication and Family Counts of All Folds
SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). The maximum number
of times SCOP families in each fold bin were reused in the same
protein was counted. For each bin, the mean count for human,
mouse, and yeast proteins is shown. As the number of families in a
SCOP fold increases, the maximum number of times families
belonging to that fold is duplicated in proteins also tends to increase.
However, the signiﬁcance of this trend could not be established. The
differences in SCOP family duplication between human, mouse, and
yeast are larger for folds with larger numbers of families. These
differences were found to be signiﬁcant between folds of one and
more than one family (MW-test, KS-test: p , 0.05).
Found at DOI: 10.1371/journal.pcbi.0020040.sg011 (23 KB PDF).
Figure S12. Fold Occurrence and Family Counts of All Folds
SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). For each bin, the mean
fold occurrence (the number of proteins the SCOP folds appear in)
for human, mouse, and yeast proteins is shown. As the number of
families in a SCOP fold increases, its occurrence in the proteome
tends to increase. The differences in fold occurrence between human,
mouse, and yeast are larger for folds with larger numbers of families.
The differences between folds with one family and folds with more
than one family within human and between the three eukaryotes are
signiﬁcant (MW-test, KS-test: p , 0.001).
Found at DOI: 10.1371/journal.pcbi.0020040.sg012 (24 KB PDF).
Figure S13. Mean Sequence Divergence and Family Counts of
Ancient Folds
Ancient SCOP folds found in E. coli proteins were compared to those
in Vibrio vulniﬁcus YJ016 and Yersinia pseudotuberculosis IP32953
orthologs, and the average divergence was recorded for each fold
(see Materials and Methods). The SCOP folds were divided into a
number of bins according to the number of families that they contain
(x-axis). The mean of the sequence identities in each bin is shown (y-
axis). For both Vibrio and Yersinia, as the number of families in a SCOP
fold increases, the sequences that encode the fold become more
divergent. The difference in conservation between folds of one family
and those of more than one family are signiﬁcant (MW-test: p , 0.02;
KS-test: p , 0.01). With respect to E. coli–Yersinia divergence, similar
signiﬁcant trends (MW-test, KS-test: p , 0.04) were also observed
when all folds were considered. With respect to divergence of all folds
between E. coli and the more distant Vibrio species, similar trends were
observed, but signiﬁcance could not be established.
Found at DOI: 10.1371/journal.pcbi.0020040.sg013 (23 KB PDF).
Figure S14. Fold Occurrence and Family Counts of c-Proteobacterial
Folds
Ancient SCOP folds were divided into a number of bins according to
the number of families that they contain (x-axis). For each bin, the
mean fold occurrence (the number of proteins in which the SCOP
folds appear) for E. coli, Y. pseudotuberculosis IP32953, and V. vulniﬁcus
YJ016 proteins is shown. As the number of families in a SCOP fold
increases, its occurrence in the proteome tends to increase. The
differences in fold occurrence between E. coli, Yersinia, and Vibrio are
larger for folds with larger numbers of families. The differences
between folds with one family and folds with more than ten families
within each bacteria and between the three bacteria are signiﬁcant
(MW-test, KS-test: p , 0.02).
Found at DOI: 10.1371/journal.pcbi.0020040.sg014 (24 KB PDF).
Figure S15. Family Occurrence and Family Counts of c-Proteobac-
terial Folds
SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). For each bin, the mean
family occurrence (the mean number of proteins, the SCOP families
in these folds appear in) for E. coli, Y. pseudotuberculosis IP32953, and V.
vulniﬁcus YJ016 proteins is shown. As the number of families in a
SCOP fold increases, the occurrence of families belonging to these
folds in the proteome tends to increase. Signiﬁcant (MW-test: p , 0.1,
KS-test: p , 0.01) occurrence differences were found between folds of
one and more than one family in E. coli and Yersinia. The trend for V.
PLoS Computational Biology | www.ploscompbiol.org May 2006 | Volume 2 | Issue 5 | e40 0400
Fold Designability, Distribution, and Diseasevulniﬁcus was found to be much weaker (MW-test: p , 0.19, KS-test: p
, 0.01).
Found at DOI: 10.1371/journal.pcbi.0020040.sg015 (23 KB PDF).
Figure S16. Fold Promiscuity and Family Counts of c-Proteobacterial
Folds
SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). SCOP folds are
connected to other ‘‘partner’’ folds in the same protein. The mean
promiscuities (the number of unique partner folds a SCOP fold has)
of folds in E. coli, Y. pseudotuberculosis IP32953, and V. vulniﬁcus YJ016
are plotted. As the number of families in a SCOP fold increases, its
promiscuity tends to increase. The differences in fold promiscuity
between E. coli, Y. pseudotuberculosis IP32953, and V. vulniﬁcus YJ016 are
larger for folds with larger numbers of families. The promiscuity
differences between and within each bacteria between folds with one
family and folds with more than ten families are signiﬁcant (MW-test,
KS-test: p , 0.02).
Found at DOI: 10.1371/journal.pcbi.0020040.sg016 (22 KB PDF).
Figure S17. Family Promiscuity and Family Counts of c-Proteobac-
terial Folds
SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). SCOP families are
connected to other ‘‘partner’’ families in the same protein. The mean
promiscuities (the number of unique partner families a SCOP family
has) of families in E. coli, Y. pseudotuberculosis IP32953, and V. vulniﬁcus
YJ016 are plotted. As the number of families in a SCOP fold increases,
the promiscuity of its families tends to increase. Mean family
promiscuity between folds of one family and folds of more than
one family were found to be signiﬁcant for E. coli (MW-test: p , 0.05,
KS-test: p , 0.01). For Yersinia and Vibrio, the difference was
statistically much weaker (MW-test: p , 0.2, KS-test: p , 0.01).
Found at DOI: 10.1371/journal.pcbi.0020040.sg017 (901 KB PDF).
Figure S18. Sequence Divergence and Fold Age
SCOP folds in human (x-axis) were compared to orthologs in mouse
and the mean sequence identity (y-axis) was recorded (see Materials
and Methods). In all comparisons, ancient folds (see Materials and
Methods) were found to be signiﬁcantly more sequence conserved
than young folds found only in human and mouse (MW-test, KS-test:
p , 0.01).
Found at DOI: 10.1371/journal.pcbi.0020040.sg018 (23 KB PDF).
Figure S19. SCOP Domain Occurrence and Fold Age
The occurrence of ancient SCOP domains (see Materials and
Methods) in the human proteome was compared to that of young
domains (appearing only in human and mouse). Ancient families
were signiﬁcantly less abundant than young families (MW-test, KS-
test: p , 0.01). At the fold level, no statistical difference in occurrence
could be established between ancient and young folds.
Found at DOI: 10.1371/journal.pcbi.0020040.sg019 (106 KB PDF).
Figure S20. SCOP Domain Duplication and Fold Age
The number of times ancient SCOP domains (see Materials and
Methods) were duplicated in the same human protein was compared
to that of young domains (appearing only in human and mouse).
Ancient families were signiﬁcantly less duplicated than young
families (MW-test: p , 0.05, KS-test: p , 0.01). At the fold level, no
statistical difference in duplication could be established between
ancient and young folds.
Found at DOI: 10.1371/journal.pcbi.0020040.sg020 (28 KB PDF).
Figure S21. SCOP Domain Promiscuity and Fold Age
The promiscuity of ancient SCOP domains (see Materials and
Methods) in the human proteome was compared to that of young
domains (appearing only in human and mouse). Ancient families
were signiﬁcantly less promiscuous than young families (MW-test: p ,
0.1, KS-test: p , 0.01). At the fold level, ancient folds were more
promiscuous than young folds (MW-test: p , 0.07, KS-test: p , 0.01).
Found at DOI: 10.1371/journal.pcbi.0020040.sg021 (23 KB PDF).
Figure S22. Length and Number of Families
The number of families in ancient SCOP folds detected in human
proteins were plotted against their length. Little correlation (R
2 ¼
 0.1) was found. A similar relation with little correlation between
length and family counts was found when all human folds were
included in the analysis (unpublished data).
Found at DOI: 10.1371/journal.pcbi.0020040.sg022 (24 KB PDF).
Figure S23. Occurrence of Human Families and Fold Class
SCOP folds were divided into a number of bins according to the
number of families that they contain (x-axis). For each bin, the mean
family occurrence (the mean number of human proteins in which
families in the SCOP folds appear) is shown, divided among ﬁve
SCOP fold classes. In general, as the number of families in a SCOP
fold increases, the occurrence of these families in the human
proteome tends to increase. A notable exception to this trend is
shown for folds classiﬁed as Other. In this class, the C2H2, Ring
ﬁnger, and the Rhodopsin-like families occupy over 500, 400, and 300
proteins, respectively, but belong to folds with only two to three
known families.
Found at DOI: 10.1371/journal.pcbi.0020040.sg023 (26 KB PDF).
Figure S24. Occurrence of Folds and Families across Genomes
SCOP folds and families were searched for (see Materials and
Methods) in proteins predicted to occur in the following genomes:
Bacteroides fragilis NCTC9434, Mus musculus, Deinococcus geothermalis,
Escherichia coli K12, Vibrio ﬁscheri ES114, Psychrobacter arcticum 273 4,
Chlorobium vibrioforme, Sulfolobus acidocaldarius DSM, Saccharomyces
cerevisiae, Mycoplasma hyopneumoniae 232, Streptococcus zooepidemicus,
and Anabaena variabilis. Folds were divided into a number of bins
according to the number of families that they contain (x-axis). The
mean number of organisms the folds (white bar) or families (black
bar) appear in is plotted for each bin. Folds containing greater
number of families tend to occur more often across organisms. Mean
genome occurrences between folds with one and more than family
were signiﬁcantly different (MW-test, KS-test: p , 0.01). However,
individual families belonging to folds with greater number of families
tend not to occur more often across these organisms.
Found at DOI: 10.1371/journal.pcbi.0020040.sg024 (23 KB PDF).
Protocol S1. Top Ten Fold Occurrence Differences between
Organism Pairs
Found at DOI: 10.1371/journal.pcbi.0020040.sd001 (11 KB DOC).
Protocol S2. Disease Proteins Containing Folds with One Family
Found at DOI: 10.1371/journal.pcbi.0020040.sd002 (16 KB DOC).
Protocol S3. List of Common Disease Proteins
Found at DOI: 10.1371/journal.pcbi.0020040.sd003 (54 KB DOC).
Protocol S4. List of Rare Disease Proteins
Found at DOI: 10.1371/journal.pcbi.0020040.sd004 (15 KB DOC).
Protocol S5. Trend Exceptions
For more information on the occurrence of human families and fold
class, see Figure S23; for more information on folds and families
across genomes, see Figure S24.
Found at DOI: 10.1371/journal.pcbi.0020040.sd005 (65 KB DOC).
Combined Supporting Information All of the supporting material is
combined into one ﬁle.
Found at DOI: 10.1371/journal.pcbi.0020040.sd006 (494 KB DOC).
Accession Numbers
The Ensembl database (http://www.ensembl.org) ID numbers for
the genes discussed in this paper are GBA-associated peptide
(ensp00000314508), G6PD (ensp00000342362), OPN1LW
(ensp00000218195), and OPNL1MW [OPN1MW] (ensp00000276343).
Acknowledgments
We thank the anonymous reviewers, Vladimir Uversky for reading a
version of the manuscript, David Liberles, members of BFAM for
insightful interaction helpful to this work, and Louise Gregory for
helpful comments and PEDANT database setup for this work.
Author contributions. PW and DF conceived and designed the
experiments. PW performed the experiments. PW and DF analyzed
the data. PW contributed reagents/materials/analysis tools. PW wrote
the paper. DF provided helpful advice throughout this work.
Funding. This work was funded by a grant of the German Federal
PLoS Computational Biology | www.ploscompbiol.org May 2006 | Volume 2 | Issue 5 | e40 0401
Fold Designability, Distribution, and DiseaseMinistry of Education and Research (BMBF) within the BFAM
framework (031U112C).
Competing interests. The authors have declared that no competing
interests exist. &
References
1. Li H, Helling R, Tang C, Wingreen N. (1996) Emergence of preferred
structures in a simple model of protein folding. Science 273: 666–669.
2. Zhang CT. (1997) Relations of the numbers of protein sequences, families
and folds. Protein Eng 10: 757–761.
3. Wingreen N, Li H, Tang C (2004) Designability and thermal stability of
protein structures. Polymer 45: 699–705.
4. England JL, Shakhnovich BE, Shakhnovich EI (2003) Natural selection of
more designable folds: a mechanism for thermophilic adaptation. Proc Natl
Acad Sci U S A 100: 8727–8731.
5. Kussell E (2005) The designability hypothesis and protein evolution.
Protein Pept Lett 12: 111–116.
6. Andreeva A, Howorth D, Brenner SE, Hubbard TJ, Chothia C, et al. (2004)
SCOP database in 2004: Reﬁnements integrate structure and sequence
family data. Nucleic Acids Res 32 (Database issue): D226–D229.
7. Wong P, Fritz A, Frishman D (2005) Designability, aggregation propensity
and duplication of disease-associated proteins. Protein Eng Des Sel 18:
503–508.
8. Ferrer-Costa C, Orozco M, de la Cruz X (2002) Characterization of disease-
associated single amino acid polymorphisms in terms of sequence and
structure properties. J Mol Biol 315: 771–786.
9. Terp BN, Cooper DN, Christensen IT, Jorgensen FS, Bross P, et al. (2002)
Assessing the relative importance of the biophysical properties of amino
acid substitutions associated with human genetic disease. Hum Mutat 20:
98–109.
10. Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs:
Server and survey. Nucleic Acids Res 30: 3894–3900.
11. Steward RE, MacArthur MW, Laskowski RA, Thornton JM (2003) Molecular
basis of inherited diseases: A structural perspective. Trends Genet 19: 505–
513.
12. Reumers J, Schymkowitz J, Ferkinghoff-Borg J, Stricher F, Serrano L, et al.
(2005) SNPeffect: A database mapping molecular phenotypic effects of
human non-synonymous coding SNPs. Nucleic Acids Res 33 (Database
issue): D527–D532.
13. Depristo MA, Weinreich DM, Hartl DL (2005) Missense meanderings in
sequence space: A biophysical view of protein evolution. Nat Rev Genet 6:
678–687.
14. Yue P, Li Z, Moult J (2005) Loss of protein structure stability as a major
causative factor in monogenic disease. J Mol Biol 353: 459–473.
15. Miller MP, Parker JD, Rissing SW, Kumar S (2003) Quantifying the
intragenic distribution of human disease mutations. Ann Hum Genet 67:
567–579.
16. Wright CF, Teichmann SA, Clarke J, Dobson CM (2005) The importance of
sequence diversity in the aggregation and evolution of proteins. Nature
438: 878–881.
17. Jimenez-Sanchez G, Childs B, Valle D (2001) Human disease genes. Nature
409: 853–855.
18. Shakhnovich BE, Deeds E, Delisi C, Shakhnovich E (2005) Protein structure
and evolutionary history determine sequence space topology. Genome Res
15: 385–392.
19. Xie L, Bourne PE (2005) Functional coverage of the human genome by
existing structures, structural genomics targets, and homology models.
PLoS Comput Biol 1: e31. DOI: 10.1371/journal.pcbi.0010031.
20. Vogel C, Teichmann SA, Pereira-Leal J (2005) The relationship between
domain duplication and recombination. J Mol Biol 346: 355–365.
21. Hegyi H, Lin J, Greenbaum D, Gerstein M (2002) Structural genomics
analysis: Characteristics of atypical, common, and horizontally transferred
folds. Proteins 47: 126–141.
22. Abeln S, Deane CM (2005) Fold usage on genomes and protein fold
evolution. Proteins 60: 690–700.
23. Alba MM, Castresana J (2005) Inverse relationship between evolutionary
rate and age of mammalian genes. Mol Biol Evol 22: 598–606.
24. Muller A, MacCallum RM, Sternberg MJ (2002) Structural characterization
of the human proteome. Genome Res 12: 1625–1641.
25. Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, et al.
(2001) Haplotype diversity and linkage disequilibrium at human G6PD:
Recent origin of alleles that confer malarial resistance. Science 293: 455–
462.
26. Beutler E, Vulliamy TJ (2002) Hematologically important mutations:
Glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis 28: 93–103.
27. Reich DE, Lander ES (2001) On the allelic spectrum of human disease.
Trends Genet 17: 502–510.
28. Lo ´pez-Bigas N, Ouzounis CA (2004) Genome-wide identiﬁcation of genes
likely to be involved in human genetic disease. Nucleic Acids Res 32: 3108–
3114.
29. Lopez-Bigas N, Audit B, Ouzounis C, Parra G, Guigo R (2005) Are splicing
mutations the most frequent cause of hereditary disease? FEBS Lett 579:
1900–1903.
30. Lupski JR (2004) Hotspots of homologous recombination in the human
genome: Not all homologous sequences are equal. Genome Biol 5: 242.
31. Ball EV, Stenson PD, Abeysinghe SS, Krawczak M, Cooper DN, et al. (2005)
Microdeletions and microinsertions causing human genetic disease:
Common mechanisms of mutagenesis and the role of local DNA sequence
complexity. Hum Mutat 26: 205–213.
32. Tayebi N, Stubbleﬁeld BK, Park JK, Orvisky E, Walker JM, et al. (2003)
Reciprocal and nonreciprocal recombination at the glucocerebrosidase
gene region: Implications for complexity in Gaucher disease. Am J Hum
Genet 72: 519–34.
33. Deeb SS (2005) The molecular basis of variation in human color vision. Clin
Genet 67: 369–377.
34. Kondrashov FA, Kondrashov AS (2006) Role of selection in ﬁxation of gene
duplications. J Theor Biol 239: 141–151. E-pub 20 October 2005. DOI:
10.1016/j.jtbi.2005.08.033
35. Shiu SH, Byrnes JK, Pan R, Zhang P, Li WH (2006) Role of positive selection
in the retention of duplicate genes in mammalian genomes. Proc Natl Acad
Sci U S A 103: 2232–2236.
36. Regan BC, Julliot C, Simmen B, Vienot F, Charles-Dominique P, et al. (2001)
Fruits, foliage and the evolution of primate colour vision. Philos Trans R
Soc Lond B Biol Sci 356: 229–283.
37. Dominy NJ, Svenning JC, Li WH (2003) Historical contingency in the
evolution of primate color vision. J Hum Evol 44: 25–45.
38. Bustamante CD, Fledel-Alon A, Williamson S, Nielsen R, Hubisz MT, et al.
(2005) Natural selection on protein-coding genes in the human genome.
Nature 437: 1153–1157.
39. Rutherford SL (2003) Between genotype and phenotype: Protein chaper-
ones and evolvability. Nat Rev Genet 4: 263–274.
40. Kolter T, Wendeler M (2003) Chemical chaperones—A new concept in drug
research. Chembiochem 4: 260–264.
41. Kerner MJ, Naylor DJ, Ishihama Y, Maier T, Chang HC, et al. (2005)
Proteome-wide analysis of chaperonin-dependent protein folding in
Escherichia coli. Cell 122: 209–220.
42. Wong P, Houry WA (2004) Chaperone networks in bacteria: Analysis of
protein homeostasis in minimal cells. J Struct Biol 146: 79–89.
43. Chirgadze DY, Demydchuk M, Becker M, Moran S, Paoli M (2004) Snapshot
of protein structure evolution reveals conservation of functional dimeriza-
tion through intertwined folding. Structure 12: 1489–1494.
44. Drummond DA, Bloom JD, Adami C, Wilke CO, Arnold FH (2005) Why
highly expressed proteins evolve slowly. Proc Natl Acad Sci U S A 102:
14338–14343.
45. Drummond DA, Raval A, Wilke CO (2006) A single determinant dominates
the rate of yeast protein evolution. Mol Biol Evol 23: 327–337.
46. Wilke CO, Drummond DA (2006) Population genetics of translational
robustness. Genetics. E-pub ahead of print 19 February 2006. DOI: 10.1534/
genetics.105.051300
47. Guo HH, Choe J, Loeb LA (2004) Protein tolerance to random amino acid
change. Proc Natl Acad Sci U S A 101: 9205–9210.
48. Socolich M, Lockless SW, Russ WP, Lee H, Gardner KH, et al. (2005)
Evolutionary information for specifying a protein fold. Nature 437: 512–
518.
49. Russ WP, Lowery DM, Mishra P, Yaffe MB, Ranganathan R (2005) Natural-
like function in artiﬁcial WW domains. Nature 437: 579–583.
50. Campbell-Valois FX, Tarassov K, Michnick SW (2005) Massive sequence
perturbation of a small protein. Proc Natl Acad Sci U S A 102: 14988–
14993.
51. Hubbard T, Andrews D, Caccamo M, Cameron G, Chen Y, et al. (2005)
Ensembl 2005. Nucleic Acids Res 33 (Database issue): D447–D453.
52. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA (2005)
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human
genes and genetic disorders. Nucleic Acids Res 33 (Database issue): D514–
D517.
53. Kasprzyk A, Keefe D, Smedley D, London D, Spooner W, et al. (2004)
EnsMart: A generic system for fast and ﬂexible access to biological data.
Genome Res 14: 160–169.
54. Riley ML, Schmidt T, Wagner C, Mewes HW, Frishman D (2005) The
PEDANT genome database in 2005. Nucleic Acids Res 33 (Database issue):
D308–D310.
55. Gu ¨ldener U, Mu ¨nsterko ¨tter M, Kastenmu ¨ller G, Strack N, van Helden J, et
al. (2005) CYGD: The Comprehensive Yeast Genome Database. Nucleic
Acids Res 33 (Database Issue): D364–D368.
56. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997)
Gapped BLAST and PSI-BLAST: A new generation of protein database
search programs. Nucleic Acids Res 25: 3389–3402.
57. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, et al. (2003) Multiple
sequence alignment with the Clustal series of programs. Nucleic Acids Res
31: 3497–3500.
PLoS Computational Biology | www.ploscompbiol.org May 2006 | Volume 2 | Issue 5 | e40 0402
Fold Designability, Distribution, and Disease